Does radiation enhance promotion of already-initiated cells in protracted high-LET carcinogenesis via a bystander effect?

International Congress Series

Volumn 1236, Issue C, 2002, Pages 283-287

  Curtis, S B ^a   Luebeck, E G ^a   Hazelton, W D ^a   Moolgavkar, S H ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Bystander effects; Carcinogenesis; High LET radiation; Multistage models; Promotion

Indexed keywords

EID: 0344083063     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(01)00772-5     Document Type: Article

References (8)

1. Kai, M., Luebeck, E.G., Moolgavkar, S.H., Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis. Radiat. Res. 148 (1997), 348–358.
2. Luebeck, E.G., Curtis, S.B., Cross, F.T., Moolgavkar, S.H., Two-stage model of radon-induced malignant lung tumors in rats: effects of cell killing. Radiat. Res. 145 (1996), 163–173.
3. Luebeck, E.G., Heidenreich, W.F., Hazelton, W.D., Paretzke, H.G., Moolgavkar, S.H., Biologically-based analysis of the Colorado uranium miners cohort data: age, dose, dose-rate effects. Radiat. Res. 152 (1999), 339–351.
4. Hazelton, W.D., Luebeck, E.G., Heidenreich, W.F., Moolgavkar, S.H., Analysis of a historical cohort of Chinese tin miners with arsenic, radon, cigarette smoke and pipe smoke exposures using the biologically based two-stage clonal expansion model. Radiat. Res. 156 (2001), 78–94.
5. Curtis, S.B., Luebeck, E.G., Hazelton, W.D., Moolgavkar, S.H., The role of promotion in carcinogenesis from protracted high-LET exposure. Phys. Med. 17:Suppl. 1 (2001), 157–160.
6. Little, J.B., Radiation carcinogenesis. Carcinogenesis 21 (2000), 397–404.
7. Barcellos-Hoff, M.-H., Ravani, S.A., Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 60 (2000), 1254–1260.
8. Iyer, R., Lehnert, B.E., Factors underlying the cell growth-related bystander responses to alpha particles. Cancer Res. 60 (2000), 1290–1298.